Restoring the balance with Regulatory T Cell Therapies
Quell Therapeutics is a London based, private biopharmaceutical company. Their vision is to be the leading engineered cell therapy company, bringing transformational and valued therapies addressing a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation.
Date: 18 January 2024, 12:00
Venue: Seminar room
Speaker: Luke Devey (Chief Medical Officer)
Organising department: Department of Paediatrics
Organiser: Sheena Lee (MSD Business Partnerships Office)
Booking required?: Not required
Booking url: https://forms.office.com/e/suZ1J5CiU1
Cost: None
Audience: Members of the University only
Editor: Laura Borg